Japanese medtech startup Medmain to expand to US
25th September, 2023
The startup develops and provides PidPort, an AI-powered cloud system that supports digital pathology
Medmain Inc, a Japanese medtech startup that offers PidPort, an artificial intelligence (AI)-powered cloud system to assist in digital pathology, has been selected for the "US Market Gateway Accelerator for BioSciences and MedTech", an acceleration programme sponsored by WorldUpstart, LLC. The firm will take advantage of this opportunity to move forward with its business development in the US.
The "US Market Gateway Accelerator for BioSciences and MedTech", sponsored by WorldUpstart, LLC, is an acceleration programme that provides medical tech and life sciences startups with a proven track record outside the US with the opportunity to enter and grow their business in the US market.
Through this programme, the startup will receive advice on business development in the US, ranging from FDA filings, marketing strategies for the US healthcare market, intellectual property strategies, financing and business alliance strategies, and promotional support, among others.
Medmain will introduce PidPort, the AI-powered cloud system designed to support digital pathology, at the upcoming "Philadelphia Alliance for Capital and Technology Conference", the largest annual startup conference in Philadelphia, which will be held in November 2023.
The startup was selected this year to receive funding from the Japan Agency for Medical Research and Development (AMED), a funding agency that plays a central role in R&D in the Japanese medical field and the development of its infrastructure.
Medtech Special
- Advanced MedTech Holdings Surges to Record US$335 Million Global Revenues, Announces CEO Transition
- Philips India partners with Star Imaging to launch the first MRI training school in India
- MediSim VR unveils India’s first VR skill training lab for nursing at KD Hospital
- Trivitron Healthcare launches new CT scanner ‘Terrene’
- Dawn Health and Merck collaborate to support Growth Disorders care
- Clarius Mobile Health gets US FDA clearance for Clarius OB AI fetal biometric measurement tool
- Israel's Medasense partners with Nihon Kohden for distribution of pain monitoring device in Japan
Artificial Intelligence Breakthroughs
- Dawn Health and Merck collaborate to support Growth Disorders care
- Israel's Medasense partners with Nihon Kohden for distribution of pain monitoring device in Japan
- AliveCor announces dual US FDA clearance of AI technology for cardiac care
- AgileMD receives US FDA clearance for eCART to predict in-hospital clinical deterioration across medical conditions
- Juniper Biologics expands distribution rights for Caris Life Sciences' molecular profiling in the Middle East and Africa
- Fischer Medical Ventures invests in Singapore's Wonder Tech to revolutionise AI-based mental healthcare
- First portable, AI-powered diabetic retinopathy screening solution for on-the-spot diagnosis
Robots In Medtech
- Nepal's first surgical robot set to transform healthcare sector
- Apollo Cancer Centres collaborates with Accuray to launch India's first robotic stereotactic radiotherapy programme
- China-based startup Ronovo Surgical raises $44 M in series B funding round
- Meril introduces advanced surgical robotic technology MISSO in India
- SS Innovations' SSi Mantra surgical robotic system receives approval for use in Indonesia
- Zimmer Biomet partners with THINK Surgical to offer robotic system for total knee arthroplasty
- 510(k) FDA clearance for J&J company DePuy Synthes for its robotic-assisted solution for knee arthroplasty
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer